VI
KDNY

Versor Investments’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Versor Investments’s Portfolio KDNY Stock Details KDNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-348,543
Closed -$13.4M – 872
2023
Q2 		$13.4M Buy
+348,543
New +$8.95M 2.32% 12

Versor Investments's KDNY Position: Q3 2023 in Review

Versor Investments sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q3 2023, closing a stake of 348,543 shares — an estimated $13.4M sold.

Versor Investments first reported a position in KDNY in Q2 2023 and held it in 1 quarter. The position peaked at $13.4M in Q2 2023. 2 funds tracked by Wall St. Rank hold KDNY as of Q3 2023.

  • Versor Investments reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Versor Investments sold 348,543 Chinook Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $13.4M.
  • Versor Investments first reported a position in Chinook Therapeutics, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
  • Versor Investments's Chinook Therapeutics, Inc. Common Stock position peaked at $13.4M in Q2 2023.
  • 2 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Versor Investments's 13F filing for Q3 2023, filed 6 Nov 2023.